P596: CLINICAL IMPACT OF TP53 DISRUPTION IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH A BCR INHIBITOR. A CAMPUS CLL EXPERIENCE.

Autor:	Bomben, R., Rossi, F. M., Vit, F., Bittolo, T., Zucchetto, A., Papotti, R., Tissino, E., Pozzo, F., Degan, M., Zaina, E., Cattarossi, I., Nanni, P., Marasca, R., Reda, G., Laurenti, L., Olivieri, J., Chiarenza, A., Ballotta, L., Cuneo, A., Gentile, M.
Zdroj:	HemaSphere; 2022 Supplement 3, Vol. 6, p495-496, 2p
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text